Skip to main content

Excessive Salivation News

Related terms: Drooling

FDA Approves Xeomin (incobotulinumtoxinA) for Adult Patients with Sialorrhea (Excessive Drooling)

RALEIGH, N.C., July 3, 2018 – Merz North America announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for Xeomin...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Oral and Dental Conditions